<code id='1CC84265A7'></code><style id='1CC84265A7'></style>
    • <acronym id='1CC84265A7'></acronym>
      <center id='1CC84265A7'><center id='1CC84265A7'><tfoot id='1CC84265A7'></tfoot></center><abbr id='1CC84265A7'><dir id='1CC84265A7'><tfoot id='1CC84265A7'></tfoot><noframes id='1CC84265A7'>

    • <optgroup id='1CC84265A7'><strike id='1CC84265A7'><sup id='1CC84265A7'></sup></strike><code id='1CC84265A7'></code></optgroup>
        1. <b id='1CC84265A7'><label id='1CC84265A7'><select id='1CC84265A7'><dt id='1CC84265A7'><span id='1CC84265A7'></span></dt></select></label></b><u id='1CC84265A7'></u>
          <i id='1CC84265A7'><strike id='1CC84265A7'><tt id='1CC84265A7'><pre id='1CC84265A7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:5552
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more
          Eli Lilly to acquire Versanis in heated race for weight loss drugs
          Eli Lilly to acquire Versanis in heated race for weight loss drugs

          DarronCummings/APEliLillysaidFridayitwillacquireVersanisBio,aprivatecompanydevelopinganobesitydrugth

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

          7:36JonHuntsmanlistenstoquestionsduringahearingaboutvotingrightsintheDistrictofColumbiabeforetheCons